Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance
ONCOLOGY · 11.06.2026 · 40 (5) · 220
DOI: 10.46883/2026.25921214 ↗Kurz gefasst
Editorial in der Zeitschrift ONCOLOGY, online erschienen am 06.07.2026. Verfasst von Nora Janjan. Hauptthemen laut MEDLINE: Drug Costs, Health Services Accessibility, Antineoplastic Agents. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
A primary driver of skyrocketing health care budgets has been the cost of prescription medications, which is particularly true for oncology, as personalized medicine is the standard of care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Janjan, N. (2026). Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance. ONCOLOGY, 40(5), 220. https://doi.org/10.46883/2026.25921214
Vancouver
Janjan N. Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance. ONCOLOGY. 2026;40(5):220. doi:10.46883/2026.25921214
BibTeX
@article{Janjan2026,
author = {Janjan, Nora},
title = {Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance},
journal = {ONCOLOGY},
year = {2026},
volume = {40},
number = {5},
pages = {220},
doi = {10.46883/2026.25921214}
}
EUVIMED